Appendix
CLAIM Study Investigators: Amin Abdelghany, MD, Panama City, FL; Allen B. Adolphe, MD, Albuquerque, NM; J. Richard Allison, MD, Columbia, SC; Norse Bear, MD, Lakewood, CO; Patricia Buchanan, MD, Eugene, OR; Michael Burleson, MD, Eureka, CA; Larry L. Carr, DO, Bay City, MI; Rogelio Cattan, MD, Miami, FL; Bronell Chandler, MD, Upper Darby, PA; Shane Christensen, MD, Salt Lake City, UT; Steven G. Chrysant, MD, Oklahoma City, OK; James L. Conrad, MD, Perkasie, PA; Lydia Corn, MD, Sarasota, FL; Robert E. Cronin, MD, Dallas, TX; Steven Curland, MD, Norwich, CT; William Dachman, MD, Mesa, AZ; Berge Dadourian, MD, Las Vegas, NV; D. Marty Denny, MD, Jeffersonville, IN; Margaret Drehobl, MD, San Diego, CA; Bonafacio Ferrer, MD, Cleveland, OH; David Fried, MD, Providence, RI; Stefan Gravenstein, MD, Norfolk, VA; Joe L. Hargrove, MD, Little Rock, AR; J. Freeman Harris, MD, Lake Oswego, OR; Terence Hart, MD, Muscle Shoals, AL; Lawrence Horwitz, MD, Denver, CO; Nazim A. Jaffer, MD, Youngstown, OH; Lois Anne Katz, MD, New York, NY; Robert Kipperman, MD, Oklahoma City, OK; Tom C. Klein, MD, Wichita, KS; Nelson Kopyt, DO, Allentown, PA; Julie A. Kovach, MD, Ann Arbor, MI; John Lafata, MD, Vista, CA; Bobby Quentin Lanier, MD, Fort Worth, TX; Kenneth Lasseter, MD, Miami, FL; Andrew J. Lewin, MD, Los Angeles, CA; Richard Maravel, MD, New Port Richey, FL; Clark D. McKeever, MD, Houston, TX; Mahendra Mirani, MD, Hamburg, NY; K. K. Mohan, MD, Essexville, MI; Jeffrey S. Morton, MD, Peoria, IL; William S. Mullican, MD, Evansville, IN; Gary Rabetoy, MD, Salt Lake City, UT; Edward Myers, DO, Warren, OH; Puneet Narayan, MD, Springfield, VA; Stephen Nash, MD, Syracuse, NY; Nicholas Nayak, MD, Normal, IL; Kuang Ou, MD, Pittsburgh, PA; John E. Pappas, MD, Lexington, KY; Jeffrey Passer, MD, Omaha, NE; Andres Patron, DO, Hollywood, FL; Robert A. Phillips, MD, New York, NY; Jacob Pinnas, MD, Tucson, AZ; Robert B. Rhoades, MD, Martinez, GA; Peter M. Ripley, MD, South Yarmouth, MA; Jeffrey S. Rosen, MD, Coral Gables, FL; Dennis Ruff, MD, San Antonio, TX; Douglas Schumacher, MD, Columbus, OH; L. Kent Smith, MD, Phoenix, AZ; David H.G. Smith, MD, Long Beach, CA; James W. Snyder, MD, Las Vegas, NV; Nina Stuccio-White, DO, Marlton, NJ; Louise Taber, MD, Phoenix, AZ; Melvin Tonkon, MD, Anaheim, CA; Timothy S. Truitt, MD, Melbourne, FL; Nostratola D. Vizari, MD, Orange, CA; Heiner Vogelbach, MD, Arcadia, CA; Jonathan Wechsler, DO, Las Vegas, NV; Kenneth Williams, MD, Baltimore, MD; Leonard Wojnowich, MD, Atlanta, GA.
We gratefully acknowledge the assistance of Channeary McDowell, BS; Jeanine Parsons, BS; Melissa Grozinski, BS; Anne Kezer, BS; Conrad Tou, PhD; Terry Flanagan, MPH; James Gaddy, PhD; Oliver Yeh, BA; and Debbie Brangman, MBA in the conduct of the study and manuscript preparation, and the diligent efforts of the study coordinators at the 72 investigative sites.
Funding informationSupported by a grant from AstraZeneca LP, Wayne, PA.
Address for correspondence/reprint requests: Rebecca Wang, MD, 725 Chesterbrook Blvd, D3W, Wayne, PA 19087-5677.
© 2001 Le Jacq Communications, Inc.
Cite this: Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The CLAIM Study - Medscape - Jan 01, 2001.